These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8742915

  • 1. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
    Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH.
    J Gastroenterol Hepatol; 1996 Mar; 11(3):208-15. PubMed ID: 8742915
    [Abstract] [Full Text] [Related]

  • 2. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J, Białek A, Caron P, Straka RJ, Heathcote J, Milkiewicz P, Barbier O.
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G, Endele R, Senn M, Stiehl A.
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [Abstract] [Full Text] [Related]

  • 5. Plasma bile acid levels and liver disease.
    Magyar I, Loi HG, Fehér T.
    Acta Med Acad Sci Hung; 1981 Jun; 38(2):109-15. PubMed ID: 7324802
    [Abstract] [Full Text] [Related]

  • 6. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
    Poupon RE, Chrétien Y, Poupon R, Paumgartner G.
    Hepatology; 1993 Apr; 17(4):599-604. PubMed ID: 8477964
    [Abstract] [Full Text] [Related]

  • 7. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats.
    Azer SA, Murray M, Farrell GC, Stacey NH.
    Hepatology; 1993 Nov; 18(5):1224-31. PubMed ID: 8225229
    [Abstract] [Full Text] [Related]

  • 8. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
    Clayton PT, Mills KA, Johnson AW, Barabino A, Marazzi MG.
    Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
    [Abstract] [Full Text] [Related]

  • 9. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.
    Kayashima A, Sujino T, Fukuhara S, Miyamoto K, Kubosawa Y, Ichikawa M, Kawasaki S, Takabayashi K, Iwasaki E, Kato M, Honda A, Kanai T, Nakamoto N.
    Hepatol Commun; 2024 Jun 01; 8(6):. PubMed ID: 38780302
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical significance of serum bile acid measurement in liver diseases.
    Morita T, Matsuyama Y, Fujimoto T, Higuchi M, Tsujii T, Matsuoka Y.
    Gastroenterol Jpn; 1978 Jun 01; 13(6):491-502. PubMed ID: 748093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sulfated and nonsulfated bile acid in human serum.
    Makino I, Nakagawa S, Shinozaki K, Mashimo K.
    Lipids; 1972 Nov 01; 7(11):750-2. PubMed ID: 4634551
    [No Abstract] [Full Text] [Related]

  • 18. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC, Wolfhagen FH, Van Berge-Henegouwen GP, Salemans JM, Tangerman A, van Buuren HR, van Hattum J, van Erpecum KJ.
    J Hepatol; 1996 Dec 01; 25(6):887-94. PubMed ID: 9007717
    [Abstract] [Full Text] [Related]

  • 19. Serum bile acids in the diagnosis of hepatobiliary disease.
    Pennington CR, Ross PE, Bouchier IA.
    Gut; 1977 Nov 01; 18(11):903-8. PubMed ID: 590851
    [Abstract] [Full Text] [Related]

  • 20. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.
    Bremmelgaard A, Almé B.
    Scand J Gastroenterol; 1980 Nov 01; 15(5):593-600. PubMed ID: 7444367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.